Validation of a Quality of Life Assessment Tool in Adult Generalized Dystonodyskinetic Syndromes Treated by Continuous Electrical Neuromodulation (DBS-QoLs)
Primary Purpose
Dystono-dyskinetic Syndromes
Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Questionnaire (DBS-QoLs)
Sponsored by
About this trial
This is an interventional supportive care trial for Dystono-dyskinetic Syndromes
Eligibility Criteria
Inclusion Criteria: Adulte between 18 an 80 years Patient with a generalized dystono-dyskinetic syndrome treated by Electrical Neuromodulation Continue and follow-up in the unit Subject affiliated to the French social security system Exclusion Criteria: non-French speaker patients who are physically unable to answer the questionnaire and who have no trusted person to help severe cognitive impairment (MoCA <10, MDRS <123, PM-38 <70) lack of informed consent
Sites / Locations
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Adults with dystono-diskinetic syndrome treated by depp brain stimulation in the unit.
Arm Description
Outcomes
Primary Outcome Measures
Ability to perform different activities assessed by DBS-QOLs
Ability to perform different activities assessed by the Dystono-dyskinetic Brethomé-Sanrey Quality of Life scale (DBS-QOLs) with the evaluation of the ability to perform different activities (from impossible to autonomous) and then to estimate the evolution of this ability since the intervention (worsening, no change, improvement)
Psycho-social assessment by DBS-QOLs
Psychosocial assessment by the "Dystono-dyskinetic Brethomé-Sanrey Quality of Life scale" (DBS-QOLs) with yes/no/partially questions related to the emotional and psychological perception of patients and then to estimate the evolution of this thought since the intervention (worsening, no change, improvement)
Intervention's assessment by DBS-QOLs
Intervention's assessment by "Dystono-dyskinetic Brethomé-Sanrey Quality of Life scale" (DBS-QOLs) with yes/no question related to the intervention.
Life's Quality assessment by DBS-QOLs
Life's Quality assessment by "Dystono-dyskinetic Brethomé-Sanrey Quality of Life scale" (DBS-QOLs) with squales from 0 (worst case) to 10 (best case).
Secondary Outcome Measures
External validity of the DBS-QOLs compared to the BFMDRS for the functional subscale
Comparison between the "Functional" subscale of the Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS) and the total score obtained on the Functional dimension (Mobility + Activity of Daily Living) of the "Dystono-dyskinetic Brethomé-Sanrey Quality of Life scale" (DBS-QOLs).
External validity of the DBS-QOLs compared to the Beck Depression Inventory score for Thumia
Comparison of the Thumia score assessed by the Beck Depression Inventory score & the "Dystono-dyskinetic Brethomé-Sanrey Quality of Life scale" (DBS-QOLs) through the answer the the emotional and psychological perception of patients which have 12 items (Impossible, third person help, technology help, autonomous)
External validity of the DBS-QOLs compared to the SF-36 for Life's quality
Comparison of the Life's quality assessed by the Short Form (36) Health Survey (SF-36) and by the "Dystono-dyskinetic Brethomé-Sanrey Quality of Life scale" (DBS-QOLs) with different yes/no question
External validity of the reproducibility of the DBS-QOLs compared to the BFMDRS
Comparison of the sentivity to change between the Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS) and the "Dystono-dyskinetic Brethomé-Sanrey Quality of Life scale" (DBS-QOLs) through the evolution of the answer of DBS-QoLs and BFMDRS during the following of the patient.
External validity according to different clinical criteria or scales : sensitivity to change
Sensitivity to change (assessment of changes during follow-up by the BFMDRS).
Assessment of the correlation between the functional fain & the benefit felt by the patient with the DBS-QOLs
Assessment of the correlation between the measure of benefit in terms of functional gain and the benefit experienced by the patient with all the answer of all module in "Dystono-dyskinetic Brethomé-Sanrey Quality of Life scale" (DBS-QOLs).
Assessment of the tolerance to surgery by the DBS-QOLs
Assessment of the tolerance to surgery through the "surgical" module of the "Dystono-dyskinetic Brethomé-Sanrey Quality of Life scale" (DBS-QOLs) which is composed of yes/no questions.
Full Information
NCT ID
NCT05870020
First Posted
April 6, 2023
Last Updated
May 19, 2023
Sponsor
University Hospital, Montpellier
1. Study Identification
Unique Protocol Identification Number
NCT05870020
Brief Title
Validation of a Quality of Life Assessment Tool in Adult Generalized Dystonodyskinetic Syndromes Treated by Continuous Electrical Neuromodulation
Acronym
DBS-QoLs
Official Title
Validation of a Quality of Life Assessment Tool in Generalized Dystonodyskinetic Syndromes Treated With Continuous Electrical Neuromodulation (CEN): The "Dystono-dyskinetic BrethoméSanrey Quality of Life" Scale (DBS-QoLs)
Study Type
Interventional
2. Study Status
Record Verification Date
May 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
May 2023 (Anticipated)
Primary Completion Date
October 2026 (Anticipated)
Study Completion Date
January 2027 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Montpellier
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
In spite of a growing interest in the evaluation of health-related quality of life in movement's disorders management, there is no tool specifically dedicated to dystonia and related syndromes that measures both the objective severity of the handicap and the patient's feelings about the surgical treatment in terms of subjective improvement. We have been working for several years at the bedside of patients operated on in the " pathologies cérébrales résistantes " Unit on the development of a related questionnaire to assess both the motor severity and the patients' feelings about the evolution of their disease under Deep Brain Stimulation (DBS).
The self-questionnaire designed would allow to a certain extent to get away from the two gold standards currently used in the field, i.e. the Burke, Fahn & Marsden Dystonia Rating Scale (BFMDRS) and the SF-36, thus facilitating the evaluation and allowing a homogenization of the practices for the different implanting centers on the french territory.
Detailed Description
The construction of the tool in its particular design, including various targeted modules, stems from an experience of more than ten years acquired with patients treated by deep brain stimulation in the unit. The self-questionnaire thus obtained will be sent to 146 patients with generalized dystonodyskinetic syndrome, operated and followed in the unit, and submitted to various statistical analyses. The scores of the identified dimensions will be compared with the etiology of the abnormal movements (primary vs. secondary) as well as with the results obtained with the two scales currently used to evaluate abnormal movements (BFMDRS) and/or quality of life (SF-36) and finally with the patients' mood during their follow-up (BDI, STAI). Tolerance to surgery will also be measured.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dystono-dyskinetic Syndromes
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
146 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Adults with dystono-diskinetic syndrome treated by depp brain stimulation in the unit.
Arm Type
Experimental
Intervention Type
Other
Intervention Name(s)
Questionnaire (DBS-QoLs)
Intervention Description
The DBS-QoLs questionnaire will be sent to the patients for answer:
The questonnaire will be sent at :
the inclusion
15 days after the inclusion
1 year after the inclusion
Primary Outcome Measure Information:
Title
Ability to perform different activities assessed by DBS-QOLs
Description
Ability to perform different activities assessed by the Dystono-dyskinetic Brethomé-Sanrey Quality of Life scale (DBS-QOLs) with the evaluation of the ability to perform different activities (from impossible to autonomous) and then to estimate the evolution of this ability since the intervention (worsening, no change, improvement)
Time Frame
1 year
Title
Psycho-social assessment by DBS-QOLs
Description
Psychosocial assessment by the "Dystono-dyskinetic Brethomé-Sanrey Quality of Life scale" (DBS-QOLs) with yes/no/partially questions related to the emotional and psychological perception of patients and then to estimate the evolution of this thought since the intervention (worsening, no change, improvement)
Time Frame
1 year
Title
Intervention's assessment by DBS-QOLs
Description
Intervention's assessment by "Dystono-dyskinetic Brethomé-Sanrey Quality of Life scale" (DBS-QOLs) with yes/no question related to the intervention.
Time Frame
1 year
Title
Life's Quality assessment by DBS-QOLs
Description
Life's Quality assessment by "Dystono-dyskinetic Brethomé-Sanrey Quality of Life scale" (DBS-QOLs) with squales from 0 (worst case) to 10 (best case).
Time Frame
1 year
Secondary Outcome Measure Information:
Title
External validity of the DBS-QOLs compared to the BFMDRS for the functional subscale
Description
Comparison between the "Functional" subscale of the Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS) and the total score obtained on the Functional dimension (Mobility + Activity of Daily Living) of the "Dystono-dyskinetic Brethomé-Sanrey Quality of Life scale" (DBS-QOLs).
Time Frame
1 year
Title
External validity of the DBS-QOLs compared to the Beck Depression Inventory score for Thumia
Description
Comparison of the Thumia score assessed by the Beck Depression Inventory score & the "Dystono-dyskinetic Brethomé-Sanrey Quality of Life scale" (DBS-QOLs) through the answer the the emotional and psychological perception of patients which have 12 items (Impossible, third person help, technology help, autonomous)
Time Frame
1 year
Title
External validity of the DBS-QOLs compared to the SF-36 for Life's quality
Description
Comparison of the Life's quality assessed by the Short Form (36) Health Survey (SF-36) and by the "Dystono-dyskinetic Brethomé-Sanrey Quality of Life scale" (DBS-QOLs) with different yes/no question
Time Frame
1 year
Title
External validity of the reproducibility of the DBS-QOLs compared to the BFMDRS
Description
Comparison of the sentivity to change between the Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS) and the "Dystono-dyskinetic Brethomé-Sanrey Quality of Life scale" (DBS-QOLs) through the evolution of the answer of DBS-QoLs and BFMDRS during the following of the patient.
Time Frame
1 year
Title
External validity according to different clinical criteria or scales : sensitivity to change
Description
Sensitivity to change (assessment of changes during follow-up by the BFMDRS).
Time Frame
1 year
Title
Assessment of the correlation between the functional fain & the benefit felt by the patient with the DBS-QOLs
Description
Assessment of the correlation between the measure of benefit in terms of functional gain and the benefit experienced by the patient with all the answer of all module in "Dystono-dyskinetic Brethomé-Sanrey Quality of Life scale" (DBS-QOLs).
Time Frame
1 year
Title
Assessment of the tolerance to surgery by the DBS-QOLs
Description
Assessment of the tolerance to surgery through the "surgical" module of the "Dystono-dyskinetic Brethomé-Sanrey Quality of Life scale" (DBS-QOLs) which is composed of yes/no questions.
Time Frame
1 year
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Adulte between 18 an 80 years
Patient with a generalized dystono-dyskinetic syndrome treated by Electrical Neuromodulation Continue and follow-up in the unit
Subject affiliated to the French social security system
Exclusion Criteria:
non-French speaker
patients who are physically unable to answer the questionnaire and who have no trusted person to help
severe cognitive impairment (MoCA <10, MDRS <123, PM-38 <70)
lack of informed consent
12. IPD Sharing Statement
Learn more about this trial
Validation of a Quality of Life Assessment Tool in Adult Generalized Dystonodyskinetic Syndromes Treated by Continuous Electrical Neuromodulation
We'll reach out to this number within 24 hrs